APTEVO THERAPEUTICS INC's ticker is APVO and the CUSIP is 03835L108. A total of 67 filers reported holding APTEVO THERAPEUTICS INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $36,000 | -53.2% | 61,727 | -28.8% | 0.00% | -50.0% |
| Q2 2019 | $77,000 | -1.3% | 86,727 | 0.0% | 0.00% | -20.0% |
| Q1 2019 | $78,000 | -29.1% | 86,727 | 0.0% | 0.01% | -28.6% |
| Q4 2018 | $110,000 | -75.1% | 86,727 | 0.0% | 0.01% | -63.2% |
| Q3 2018 | $441,000 | -25.5% | 86,727 | -27.0% | 0.02% | -32.1% |
| Q2 2018 | $592,000 | -8.5% | 118,736 | -40.0% | 0.03% | -12.5% |
| Q1 2018 | $647,000 | -31.1% | 197,986 | -10.6% | 0.03% | -30.4% |
| Q4 2017 | $939,000 | +35.7% | 221,380 | -26.7% | 0.05% | +35.3% |
| Q3 2017 | $692,000 | -5.6% | 301,980 | -14.7% | 0.03% | -5.6% |
| Q2 2017 | $733,000 | +0.5% | 353,977 | 0.0% | 0.04% | -18.2% |
| Q1 2017 | $729,000 | -15.6% | 353,977 | 0.0% | 0.04% | -6.4% |
| Q4 2016 | $864,000 | -4.6% | 353,977 | 0.0% | 0.05% | +6.8% |
| Q3 2016 | $906,000 | – | 353,977 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sessa Capital IM, L.P. | 1,021,836 | $1,298,000 | 0.18% |
| HighVista Strategies LLC | 79,568 | $101,000 | 0.09% |
| ATLAS CAPITAL ADVISORS LLC | 49,045 | $62,287,000 | 0.02% |
| Spark Investment Management LLC | 135,600 | $172,000 | 0.01% |
| Park West Asset Management LLC | 165,520 | $210,000 | 0.01% |
| CSS LLC/IL | 86,727 | $110,000 | 0.01% |
| Meridian Wealth Advisors, LLC | 5,000 | $6,000 | 0.01% |
| ACADIAN ASSET MANAGEMENT LLC | 462,824 | $587,000 | 0.00% |
| OXFORD ASSET MANAGEMENT LLP | 101,014 | $128,000 | 0.00% |
| SFMG, LLC | 15,544 | $20,000 | 0.00% |